Todd Foley

Todd Foley, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Rhythm Pharmaceuticals, Inc., Repare Therapeutics Inc. and Aktis Oncology, Inc. We count 65 filings; the first trade dates from 10 October 2017 and the latest from 12 January 2026.

Both buying and selling appear: 2 purchases worth €5.9M, against 58 sales worth €28.4M. Sales outweigh purchases by €22.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The record was last updated on 14 January 2026 with a transaction in Aktis Oncology, Inc. The latest purchase dates back some time: it was published 2,308 days ago, on 25 June 2020. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.